| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ginkgo Bioworks Holdings, Inc. (DNA) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. DNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 24.3K | $222.9K | - | |
| Other | 7.5K | $68.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Coen Steven P.70 | See Remarks | Sale+OE | 395 | $7.73 | $3,051.38 | -4.7% | -12.2% | -17.6% | |
| Mar 4, 2025 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 790 | $7.73 | $6,102.75 | -2.2% | -12.2% | -17.6% | |
| Feb 4, 2025 | Coen Steven P.70 | See Remarks | Sale+OE | 367 | $13.44 | $4,933.58 | -4.6% | -51.6% | -42.1% | |
| Feb 4, 2025 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 740 | $13.44 | $9,947.82 | -2.1% | -51.6% | -42.1% | |
| Jan 6, 2025 | Coen Steven P.70 | See Remarks | Sale+OE | 324 | $11.72 | $3,796.63 | -4.3% | -45.0% | -21.3% | |
| Jan 6, 2025 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 645 | $11.72 | $7,558.11 | -1.9% | -45.0% | -21.3% | |
| Dec 4, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 741 | $9.64 | $7,146.20 | -2.2% | -22.0% | -11.5% | |
| Dec 4, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 330 | $9.64 | $3,182.52 | -4.6% | -22.0% | -11.5% | |
| Nov 4, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 333 | $7.58 | $2,522.81 | -4.9% | +68.4% | +51.9% | |
| Nov 4, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 1,322 | $7.58 | $10,015.47 | -4.0% | +68.4% | +51.9% |